High-Grade Glioma, NOS — Trials

High-Grade Glioma, NOS — Trials · CancerIndex

Clinical trials

Registered studies

173 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 75
Recruiting: 47
Ph III recruiting: 1
Growth YoY: —
Industry share: 29%
Top sponsor: Nationwide Children's Hospital
Termination share: 44.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (30)

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07389278	Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)	not yet recruiting	Phase 1 / Phase 2	97	Sabine Mueller, MD, PhDOTHER	1	Sep 15, 2026	clinicaltrials
NCT06946680	IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)(Peds IMPACT)	not yet recruiting	Phase 1	24	University of FloridaOTHER	1